8-K: Sleep Number Q1 2026 Results: Sales Decline Amid Turnaround Efforts

Sleep Number reported first quarter 2026 results with net sales down 18.9% to $319 million, driven by lower volume and store count, while focusing on a turnaround strategy and capital structure solutions.

Summary

• Sleep Number announced its first quarter 2026 results, reporting net sales of $319 million, an 18.9% decrease year-over-year.
• The decline in sales was attributed to lower sales volume and a reduced number of stores.
• Gross profit decreased by $56 million to $185 million, with gross profit margin falling to 57.9% from 61.2% due to a shift in product mix and discounting of legacy inventory.
• Operating expenses were $221 million, but adjusted operating expenses (excluding restructuring costs) decreased by 18% to $195 million.
• The company reported a net loss of $50 million for the quarter, compared to a net loss of $9 million in the prior year.
• Adjusted EBITDA was $6 million, a 74% decrease year-over-year, with an Adjusted EBITDA margin of 1.8%.
• The company is focused on executing a turnaround strategy involving product innovation, modernized marketing, and cost structure reset, aiming for sustainable growth.
• Sleep Number is also actively evaluating strategic and financing options to secure a long-term capital structure solution.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative sentiment score due to significant sales declines, widening net loss, and reduced profitability, despite management's efforts to frame results as 'as expected' and highlight turnaround progress.

Positives

• Year-over-year demand improved steadily throughout the first quarter, ending with growth in March.
• Early positive metrics are being observed from the new product launch and marketing campaigns.
• Customer feedback on new beds is reported as fantastic.
• The company has achieved approximately $200 million of annualized cost savings.
• An agreement with existing lenders provides relief from certain financial covenants and adds $55 million of incremental liquidity, including a new $25 million term loan.
• Adjusted operating expenses decreased by $42 million, or 18%, driven by lower marketing, selling, G&A, and R&D expenses.
• Net cash used in year-to-date operating activities decreased by $5 million compared to the prior year.

Negatives

• Net sales decreased by 18.9% to $319 million.
• Gross profit margin declined to 57.9% from 61.2%.
• Net loss widened to $50 million from $9 million in the prior year.
• Adjusted EBITDA decreased by 74% to $6 million.
• Adjusted EBITDA margin declined by 380 basis points to 1.8%.
• Free cash flow for the quarter was a use of $13.2 million.
• The company is not providing financial guidance due to the ongoing strategic review process.
• The company's ability to continue as a going concern is mentioned as a risk.

Risks

• The company's ability to continue as a going concern.
• Risks and uncertainties detailed in the company's filings with the SEC, including Item 1A of its Annual Report on Form 10-K.
• The company's ability to secure a long-term capital solution through an evaluation of strategic and financing options.
• Potential for future results to differ materially from forward-looking statements due to various risks and uncertainties.
• The impact of a shift in product mix to the new ComfortMode bed and discounting of legacy inventory on gross profit margin.
• The ongoing evaluation of strategic and financing options may not result in a favorable outcome for stakeholders.

Future Outlook

The company is not providing financial guidance due to its ongoing engagement of advisors to evaluate strategic and financing options. However, it expects performance to be consistent with the financial indications provided on the 2025 fourth quarter and full year earnings call. The company does not intend to provide forward-looking financial guidance while the strategic process is ongoing.

Management Comments

• "Q1 came in as expected given the soft start to the year, but year-over-year demand improved steadily throughout the quarter, ending with growth in March over last year."
• "We are confident in the early positive metrics we are seeing from our new product launch and marketing campaigns, and the customer feedback on our new beds is fantastic."
• "We believe this, combined with the full realization of our cost savings actions, puts us in line with the financial indications we highlighted in the previous earnings call."
• "With the additional short-term liquidity provided by our existing lender group, we are fully focused on securing a long-term capital solution and are moving through the process of evaluating a range of strategic and financing options to maximize stakeholder value."
• "I'm proud of the significant progress the team has made on the turnaround, and I believe we have positioned Sleep Number well for future growth."

Industry Context

StockSavvy.ai notes that Sleep Number's Q1 2026 results reflect ongoing challenges within the mattress and bedding retail sector, characterized by shifts in consumer spending and the need for product innovation. The company's focus on a 'product and brand reset' aligns with industry trends emphasizing personalized comfort and wellness, while the capital structure review highlights the financial pressures many companies face in the current economic climate.

Comparison to Industry Standards

• The decline in net sales (18.9%) is significant and suggests a performance below the average for retailers in the home goods sector, which have seen varied performance depending on product category and consumer demand.
• The decrease in gross profit margin, while partly attributed to product mix, is a concern when compared to industry benchmarks that often aim for stable or improving margins through efficient operations and premium product offerings.
• The focus on a 'turnaround strategy' and 'cost savings' is common among companies facing market headwinds, but the scale of the net loss and Adjusted EBITDA decline indicates Sleep Number is experiencing more pronounced challenges than some competitors who may be reporting more stable or growth-oriented results.
• Competitors like Tempur Sealy and Serta Simmons Bedding (though privately held) are also navigating market dynamics, but Sleep Number's specific challenges with sales volume and store count appear to be more acute in this reporting period.

Stakeholder Impact

• Shareholders: Potential dilution from future capital raises, ongoing uncertainty regarding the company's financial stability and turnaround success.
• Creditors: The agreement with lenders provides short-term stability, but the long-term capital structure solution is critical for future debt servicing.
• Employees: Continued focus on cost savings and operational efficiencies may impact staffing levels.
• Suppliers: Potential impact on payment terms or order volumes depending on the company's financial performance and strategic decisions.

Next Steps

• Continue executing the turnaround strategy centered on product, marketing, and distribution.
• Continue ongoing cost savings and operating efficiencies.
• Evaluate a range of strategic and financing options for a longer-term capital structure solution.
• Focus on securing a long-term capital solution.

Key Dates

Recommendation

The company is in a critical turnaround phase with significant financial challenges, including a widening net loss and reduced profitability. While management highlights progress in product and cost savings, the ongoing strategic review and lack of financial guidance create substantial uncertainty. The stock is best held pending clearer visibility on the long-term capital structure and the success of the turnaround strategy.

Keywords

Sleep Number, SNBR, 8-K, Quarterly Results, Financial Report, Net Sales, Adjusted EBITDA, Turnaround Strategy